Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31495217 | 0.88 | ALDH1A1 (0.30) | ALDH1A1POLBSMN1; SMN2 | |
| SCHEMBL30733904 | 0.88 | ALDH1A1 (0.30) | ALDH1A1POLBSMN1; SMN2 | |
| SCHEMBL30733942 | 0.86 | MLYCD (0.31) | — | |
| SCHEMBL31547723 | 0.80 | — | — | |
| SCHEMBL31671121 | 0.80 | NR1H2 (0.43) | — | |
| SCHEMBL5586258 | 0.80 | ALDH1A1 (0.33) | ALDH1A1POLBSMN1; SMN2 | |
| SCHEMBL16577616 | 0.79 | — | — | |
| SCHEMBL5586169 | 0.78 | MEN1 (0.36) | ALDH1A1POLBSMN1; SMN2 | |
| SCHEMBL5586241 | 0.77 | FAAH (0.45) | — | |
| SCHEMBL30733918 | 0.77 | MLYCD (0.33) | SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250253397-A1 | ANION RECEPTOR COMPOUND AND ELECTROLYTE CONTAINING SAME | Zain Energy Inc. (KR) | 2025-08-07 | — | — | US | disclosed |
| EP-4549443-A1 | NOVEL ANION RECEPTOR COMPOUND AND ELECTROLYTE CONTAINING SAME | Zain Energy Inc. (KR) | 2025-05-07 | — | — | EP | disclosed |
| WO-2024005524-A1 | NOVEL ANION RECEPTOR COMPOUND AND ELECTROLYTE CONTAINING SAME | 자인에너지 주식회사 | 2024-01-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250253397-A1 | ANION RECEPTOR COMPOUND AND ELECTROLYTE CONTAINING SAME | OR51E2, SIGMAR1, SLC26A3 | ALDH1A1 3271/4885POLB 2521/4885SMN1; SMN2 2704/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.